{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:43:59Z","timestamp":1786981439402,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260051"],"award-info":[{"award-number":["82260051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693328"],"award-info":[{"award-number":["2021M693328"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11010-024-05126-6","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:01:32Z","timestamp":1728086492000},"page":"1555-1567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gene expression profiles, potential targets and treatments of cardiac remodeling"],"prefix":"10.1007","volume":"480","author":[{"given":"Dong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penglin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,5]]},"reference":[{"key":"5126_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41569-023-00887-x","volume":"20","author":"J Ritterhoff","year":"2023","unstructured":"Ritterhoff J, Tian R (2023) Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. Nat Rev Cardiol 20:812\u2013829. https:\/\/doi.org\/10.1038\/s41569-023-00887-x","journal-title":"Nat Rev Cardiol"},{"key":"5126_CR2","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2021","unstructured":"GBD 2021 Causes of Death Collaborators (2021) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403:2100\u20132132. https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2","journal-title":"Lancet"},{"key":"5126_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/ijms25021082","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS (2024) The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci 25:1082. https:\/\/doi.org\/10.3390\/ijms25021082","journal-title":"Int J Mol Sci"},{"key":"5126_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/CIRCRESAHA.122.322244","volume":"133","author":"J Shi","year":"2023","unstructured":"Shi J, Yang C, Zhang J, Zhao K, Li P, Kong C, Wu X, Sun H, Zheng R, Sun W, Chen L, Kong X (2023) NAT10 Is Involved in cardiac remodeling through ac4C-mediated transcriptomic regulation. Circ Res 133:989\u20131002. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.322244","journal-title":"Circ Res"},{"key":"5126_CR5","doi-asserted-by":"publisher","first-page":"166297","DOI":"10.1016\/j.bbadis.2021.166297","volume":"1868","author":"MD Martens","year":"2022","unstructured":"Martens MD, Karch J, Gordon JW (2022) The molecular mosaic of regulated cell death in the cardiovascular system. Biochim Biophys Acta Mol Basis Dis 1868:166297. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166297","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5126_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J (2018) Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 15:387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y","journal-title":"Nat Rev Cardiol"},{"key":"5126_CR7","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1161\/CIRCULATIONAHA.120.047000","volume":"143","author":"H Lin","year":"2021","unstructured":"Lin H, Zhu Y, Zheng C, Hu D, Ma S, Chen L, Wang Q, Chen Z, Xie J, Yan Y, Huang X, Liao W, Kitakaze M, Bin J, Liao Y (2021) Antihypertrophic memory after regression of exercise-induced physiological myocardial hypertrophy is mediated by the long noncoding RNA Mhrt779. Circulation 143:2277\u20132292. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047000","journal-title":"Circulation"},{"key":"5126_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/cvr\/cvu072","volume":"103","author":"D Fan","year":"2014","unstructured":"Fan D, Takawale A, Basu R, Patel V, Lee J, Kandalam V, Wang X, Oudit GY, Kassiri Z (2014) Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Cardiovasc Res 103:268\u2013280. https:\/\/doi.org\/10.1093\/cvr\/cvu072","journal-title":"Cardiovasc Res"},{"key":"5126_CR9","doi-asserted-by":"publisher","first-page":"750626","DOI":"10.3389\/fmolb.2021.750626","volume":"8","author":"D Fan","year":"2021","unstructured":"Fan D, Kassiri Z (2021) Modulation of cardiac fibrosis in and beyond cells. Front Mol Biosci 8:750626. https:\/\/doi.org\/10.3389\/fmolb.2021.750626","journal-title":"Front Mol Biosci"},{"key":"5126_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"D Fan","year":"2012","unstructured":"Fan D, Takawale A, Lee J, Kassiri Z (2012) Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenes Tissue Repair 5:15. https:\/\/doi.org\/10.1186\/1755-1536-5-15","journal-title":"Fibrogenes Tissue Repair"},{"key":"5126_CR11","doi-asserted-by":"publisher","first-page":"112314","DOI":"10.1016\/j.ejmech.2020.112314","volume":"197","author":"H Pang","year":"2020","unstructured":"Pang H, Wang N, Chai J, Wang X, Zhang Y, Bi Z, Wu W, He G (2020) Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury. Eur J Med Chem 197:112314. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112314","journal-title":"Eur J Med Chem"},{"key":"5126_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","volume":"35","author":"Q Xiang","year":"2024","unstructured":"Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS (2024) Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metab 35:219\u2013234. https:\/\/doi.org\/10.1016\/j.tem.2023.10.010","journal-title":"Trends Endocrinol Metab"},{"key":"5126_CR13","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1038\/s41467-018-06639-7","volume":"9","author":"S Nomura","year":"2018","unstructured":"Nomura S, Satoh M, Fujita T, Higo T, Sumida T, Ko T, Yamaguchi T, Tobita T, Naito AT, Ito M, Fujita K, Harada M, Toko H, Kobayashi Y, Ito K, Takimoto E, Akazawa H, Morita H, Aburatani H, Komuro I (2018) Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure. Nat Commun 9:4435. https:\/\/doi.org\/10.1038\/s41467-018-06639-7","journal-title":"Nat Commun"},{"key":"5126_CR14","doi-asserted-by":"publisher","first-page":"167048","DOI":"10.1016\/j.bbadis.2024.167048","volume":"1870","author":"QY Lin","year":"2024","unstructured":"Lin QY, Yu WJ, Bai J, Jiang WX, Li HH (2024) Mac-1 deficiency ameliorates pressure overloaded heart failure through inhibiting macrophage polarization and activation. Biochim Biophys Acta Mol Basis Dis 1870:167048. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167048","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5126_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/atvbaha.123.319601","volume":"44","author":"X He","year":"2024","unstructured":"He X, Cantrell AC, Williams QA, Gu W, Chen Y, Chen JX, Zeng H (2024) p53 acetylation exerts critical roles in pressure overload-induced coronary microvascular dysfunction and heart failure in mice. Arterioscler Thromb Vasc Biol 44:826\u2013842. https:\/\/doi.org\/10.1161\/atvbaha.123.319601","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5126_CR16","doi-asserted-by":"publisher","first-page":"e21892","DOI":"10.1016\/j.heliyon.2023.e21892","volume":"9","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Cai MM, Li D, Zhao BY, Zhou SS, Wu ZR, Shi YJ, Su L (2023) S14G-humanin confers cardioprotective effects against chronic adrenergic and pressure overload-induced heart failure in mice. Heliyon 9:e21892. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21892","journal-title":"Heliyon"},{"key":"5126_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/CIRCRESAHA.118.313854","volume":"124","author":"EA Blackwood","year":"2019","unstructured":"Blackwood EA, Hofmann C, Santo Domingo M, Bilal AS, Sarakki A, Stauffer W, Arrieta A, Thuerauf DJ, Kolkhorst FW, Muller OJ, Jakobi T, Dieterich C, Katus HA, Doroudgar S, Glembotski CC (2019) ATF6 regulates cardiac hypertrophy by transcriptional induction of the mTORC1 activator, Rheb. Circ Res 124:79\u201393. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313854","journal-title":"Circ Res"},{"key":"5126_CR18","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/cvr\/cvaa233","volume":"117","author":"M Vigil-Garcia","year":"2021","unstructured":"Vigil-Garcia M, Demkes CJ, Eding JEC, Versteeg D, de Ruiter H, Perini I, Kooijman L, Gladka MM, Asselbergs FW, Vink A, Harakalova M, Bossu A, van Veen TAB, Boogerd CJ, van Rooij E (2021) Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling. Cardiovasc Res 117:1532\u20131545. https:\/\/doi.org\/10.1093\/cvr\/cvaa233","journal-title":"Cardiovasc Res"},{"key":"5126_CR19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/circheartfailure.114.001469","volume":"7","author":"L Lai","year":"2014","unstructured":"Lai L, Leone TC, Keller MP, Martin OJ, Broman AT, Nigro J, Kapoor K, Koves TR, Stevens R, Ilkayeva OR, Vega RB, Attie AD, Muoio DM, Kelly DP (2014) Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach. Circ Heart Fail 7:1022\u20131031. https:\/\/doi.org\/10.1161\/circheartfailure.114.001469","journal-title":"Circ Heart Fail"},{"key":"5126_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.matbio.2012.11.011","volume":"32","author":"B Skrbic","year":"2013","unstructured":"Skrbic B, Bj\u00f8rnstad JL, Marstein HS, Carlson CR, Sjaastad I, Nyg\u00e5rd S, Bj\u00f8rnstad S, Christensen G, T\u00f8nnessen T (2013) Differential regulation of extracellular matrix constituents in myocardial remodeling with and without heart failure following pressure overload. Matrix Biol 32:133\u2013142. https:\/\/doi.org\/10.1016\/j.matbio.2012.11.011","journal-title":"Matrix Biol"},{"key":"5126_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","volume":"87","author":"FG Spinale","year":"2007","unstructured":"Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87:1285\u20131342. https:\/\/doi.org\/10.1152\/physrev.00012.2007","journal-title":"Physiol Rev"},{"key":"5126_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10741-011-9266-y","volume":"17","author":"L Moore","year":"2012","unstructured":"Moore L, Fan D, Basu R, Kandalam V, Kassiri Z (2012) Tissue inhibitor of metalloproteinases (TIMPs) in heart failure. Heart Fail Rev 17:693\u2013706. https:\/\/doi.org\/10.1007\/s10741-011-9266-y","journal-title":"Heart Fail Rev"},{"key":"5126_CR23","doi-asserted-by":"publisher","first-page":"R1597","DOI":"10.1152\/ajpregu.00825.2009","volume":"298","author":"D Fliegner","year":"2010","unstructured":"Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U, Gustafsson JA, Regitz-Zagrosek V (2010) Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 298:R1597\u2013R1606. https:\/\/doi.org\/10.1152\/ajpregu.00825.2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5126_CR24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.123.065440","volume":"149","author":"Z Ren","year":"2024","unstructured":"Ren Z, Zhao W, Li D, Yu P, Mao L, Zhao Q, Yao L, Zhang X, Liu Y, Zhou B, Wang L (2024) INO80-dependent remodeling of transcriptional regulatory network underlies the progression of heart failure. Circulation 149:1121\u20131138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065440","journal-title":"Circulation"},{"key":"5126_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41419-023-05665-8","volume":"14","author":"A Moustafa","year":"2023","unstructured":"Moustafa A, Hashemi S, Brar G, Grigull J, Ng SHS, Williams D, Schmitt-Ulms G, McDermott JC (2023) The MEF2A transcription factor interactome in cardiomyocytes. Cell Death Dis 14:240. https:\/\/doi.org\/10.1038\/s41419-023-05665-8","journal-title":"Cell Death Dis"},{"key":"5126_CR26","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1038\/s41598-017-04762-x","volume":"7","author":"SW Tobin","year":"2017","unstructured":"Tobin SW, Hashemi S, Dadson K, Turdi S, Ebrahimian K, Zhao J, Sweeney G, Grigull J, McDermott JC (2017) Heart failure and MEF2 transcriptome dynamics in response to \u03b2-blockers. Sci Rep 7:4476. https:\/\/doi.org\/10.1038\/s41598-017-04762-x","journal-title":"Sci Rep"},{"key":"5126_CR27","doi-asserted-by":"publisher","first-page":"14471","DOI":"10.1073\/pnas.0602543103","volume":"103","author":"E Bisping","year":"2006","unstructured":"Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR, Rajagopal S, Son JK, Ma Q, Springer Z, Kang PM, Izumo S, Pu WT (2006) Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 103:14471\u201314476. https:\/\/doi.org\/10.1073\/pnas.0602543103","journal-title":"Proc Natl Acad Sci USA"},{"key":"5126_CR28","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3892\/ijmm.2019.4291","volume":"44","author":"HB Wang","year":"2019","unstructured":"Wang HB, Huang R, Yang K, Xu M, Fan D, Liu MX, Huang SH, Liu LB, Wu HM, Tang QZ (2019) Identification of differentially expressed genes and preliminary validations in cardiac pathological remodeling induced by transverse aortic constriction. Int J Mol Med 44:1447\u20131461. https:\/\/doi.org\/10.3892\/ijmm.2019.4291","journal-title":"Int J Mol Med"},{"key":"5126_CR29","doi-asserted-by":"publisher","first-page":"H472","DOI":"10.1152\/ajpheart.00244.2019","volume":"317","author":"YT Wang","year":"2019","unstructured":"Wang YT, Lim Y, McCall MN, Huang KT, Haynes CM, Nehrke K, Brookes PS (2019) Cardioprotection by the mitochondrial unfolded protein response requires ATF5. Am J Physiol Heart Circ Physiol 317:H472\u2013H478. https:\/\/doi.org\/10.1152\/ajpheart.00244.2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5126_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1161\/01.RES.0000220643.65941.8d","volume":"98","author":"JJ Martindale","year":"2006","unstructured":"Martindale JJ, Fernandez R, Thuerauf D, Whittaker R, Gude N, Sussman MA, Glembotski CC (2006) Endoplasmic reticulum stress gene induction and protection from ischemia\/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res 98:1186\u20131193. https:\/\/doi.org\/10.1161\/01.RES.0000220643.65941.8d","journal-title":"Circ Res"},{"key":"5126_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41467-020-20361-3","volume":"12","author":"MM Gladka","year":"2021","unstructured":"Gladka MM, Kohela A, Molenaar B, Versteeg D, Kooijman L, Monshouwer-Kloots J, Kremer V, Vos HR, Huibers MMH, Haigh JJ, Huylebroeck D, Boon RA, Giacca M, van Rooij E (2021) Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner. Nat Commun 12:84. https:\/\/doi.org\/10.1038\/s41467-020-20361-3","journal-title":"Nat Commun"},{"key":"5126_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12933-024-02329-5","volume":"23","author":"M Cherpaz","year":"2024","unstructured":"Cherpaz M, Meugnier E, Seillier G, Pozzi M, Pierrard R, Leboube S, Farhat F, Vola M, Obadia JF, Amaz C, Chalabreysse L, May C, Chanon S, Brun C, Givre L, Bidaux G, Mewton N, Derumeaux G, Bergerot C, Paillard M, Thibault H (2024) Myocardial transcriptomic analysis of diabetic patients with aortic stenosis: key role for mitochondrial calcium signaling. Cardiovasc Diabetol 23:239. https:\/\/doi.org\/10.1186\/s12933-024-02329-5","journal-title":"Cardiovasc Diabetol"},{"key":"5126_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4239\/wjd.v12.i4.383","volume":"12","author":"J Rajbhandari","year":"2021","unstructured":"Rajbhandari J, Fernandez CJ, Agarwal M, Yeap BXY, Pappachan JM (2021) Diabetic heart disease: a clinical update. World J Diabetes 12:383\u2013406. https:\/\/doi.org\/10.4239\/wjd.v12.i4.383","journal-title":"World J Diabetes"},{"key":"5126_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH (2018) Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol 17:83. https:\/\/doi.org\/10.1186\/s12933-018-0728-6","journal-title":"Cardiovasc Diabetol"},{"key":"5126_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10741-018-9749-1","volume":"24","author":"B Parim","year":"2019","unstructured":"Parim B, Sathibabu Uddandrao VV, Saravanan G (2019) Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy. Heart Fail Rev 24:279\u2013299. https:\/\/doi.org\/10.1007\/s10741-018-9749-1","journal-title":"Heart Fail Rev"},{"key":"5126_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41392-022-01054-3","volume":"7","author":"F Xue","year":"2022","unstructured":"Xue F, Cheng J, Liu Y, Cheng C, Zhang M, Sui W, Chen W, Hao P, Zhang Y, Zhang C (2022) Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. Signal Transduct Target Ther 7:259. https:\/\/doi.org\/10.1038\/s41392-022-01054-3","journal-title":"Signal Transduct Target Ther"},{"key":"5126_CR37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/HYPERTENSIONAHA.116.07566","volume":"68","author":"D Fan","year":"2016","unstructured":"Fan D, Takawale A, Shen M, Samokhvalov V, Basu R, Patel V, Wang X, Fernandez-Patron C, Seubert JM, Oudit GY, Kassiri Z (2016) A disintegrin and metalloprotease-17 regulates pressure overload-induced myocardial hypertrophy and dysfunction through proteolytic processing of integrin beta1. Hypertension 68:937\u2013948. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07566","journal-title":"Hypertension"},{"key":"5126_CR38","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCHEARTFAILURE.114.002029","volume":"8","author":"D Fan","year":"2015","unstructured":"Fan D, Takawale A, Shen M, Wang W, Wang X, Basu R, Oudit GY, Kassiri Z (2015) Cardiomyocyte A disintegrin and metalloproteinase 17 (ADAM17) is essential in post-myocardial infarction repair by regulating angiogenesis. Circ Heart Fail 8:970\u2013979. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.002029","journal-title":"Circ Heart Fail"},{"key":"5126_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","volume":"11","author":"F Jiang","year":"2014","unstructured":"Jiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C (2014) Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets. Nat Rev Cardiol 11:413\u2013426. https:\/\/doi.org\/10.1038\/nrcardio.2014.59","journal-title":"Nat Rev Cardiol"},{"key":"5126_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00109-014-1149-y","volume":"92","author":"W Wang","year":"2014","unstructured":"Wang W, Patel VB, Parajuli N, Fan D, Basu R, Wang Z, Ramprasath T, Kassiri Z, Penninger JM, Oudit GY (2014) Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease. J Mol Med (Berl) 92:847\u2013858. https:\/\/doi.org\/10.1007\/s00109-014-1149-y","journal-title":"J Mol Med (Berl)"},{"key":"5126_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","volume":"66","author":"VB Patel","year":"2014","unstructured":"Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, Basu R, Putko B, Kassiri Z, Turner AJ, Oudit GY (2014) Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol 66:167\u2013176. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.11.017","journal-title":"J Mol Cell Cardiol"},{"key":"5126_CR42","doi-asserted-by":"publisher","first-page":"e0177988","DOI":"10.1371\/journal.pone.0177988","volume":"12","author":"M Tsuji","year":"2017","unstructured":"Tsuji M, Kawasaki T, Matsuda T, Arai T, Gojo S, Takeuchi JK (2017) Sexual dimorphisms of mRNA and miRNA in human\/murine heart disease. PLoS ONE 12:e0177988. https:\/\/doi.org\/10.1371\/journal.pone.0177988","journal-title":"PLoS ONE"},{"key":"5126_CR43","doi-asserted-by":"publisher","first-page":"eadn3510","DOI":"10.1126\/sciadv.adn3510","volume":"10","author":"AK McClain","year":"2024","unstructured":"McClain AK, Monteleone PP, Zoldan J (2024) Sex in cardiovascular disease: why this biological variable should be considered in in vitro models. Sci Adv 10:eadn3510. https:\/\/doi.org\/10.1126\/sciadv.adn3510","journal-title":"Sci Adv"},{"key":"5126_CR44","doi-asserted-by":"publisher","first-page":"H459","DOI":"10.1152\/ajpheart.00727.2023","volume":"326","author":"ML Lindsey","year":"2024","unstructured":"Lindsey ML, Usselman CW, Ripplinger CM, Carter JR, DeLeon-Pennell KY (2024) Sex as a biological variable for cardiovascular physiology. Am J Physiol Heart Circ Physiol 326:H459\u2013H469. https:\/\/doi.org\/10.1152\/ajpheart.00727.2023","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5126_CR45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/14789450.2019.1664293","volume":"16","author":"KY DeLeon-Pennell","year":"2019","unstructured":"DeLeon-Pennell KY, Lindsey ML (2019) Somewhere over the sex differences rainbow of myocardial infarction remodeling: hormones, chromosomes, inflammasome, oh my. Expert Rev Proteom 16:933\u2013940. https:\/\/doi.org\/10.1080\/14789450.2019.1664293","journal-title":"Expert Rev Proteom"},{"key":"5126_CR46","doi-asserted-by":"publisher","first-page":"H204","DOI":"10.1152\/ajpheart.00654.2021","volume":"323","author":"M Ruppert","year":"2022","unstructured":"Ruppert M, Barta BA, Korkmaz-Ic\u00f6z S, Loganathan S, Ol\u00e1h A, Sayour AA, Benke K, Nagy D, B\u00e1lint T, Karck M, Schilling O, Merkely B, Radovits T, Szab\u00f3 G (2022) Sex similarities and differences in the reverse and anti-remodeling effect of pressure unloading therapy in a rat model of aortic banding and debanding. Am J Physiol-Heart Circ Physiol 323:H204\u2013H222. https:\/\/doi.org\/10.1152\/ajpheart.00654.2021","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"5126_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00109-021-02169-w","volume":"100","author":"C Ferreira","year":"2022","unstructured":"Ferreira C, Trindade F, Ferreira R, Neves JS, Leite-Moreira A, Amado F, Santos M, Nogueira-Ferreira R (2022) Sexual dimorphism in cardiac remodeling: the molecular mechanisms ruled by sex hormones in the heart. J Mol Med 100:245\u2013267. https:\/\/doi.org\/10.1007\/s00109-021-02169-w","journal-title":"J Mol Med"},{"key":"5126_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jacc.2011.09.054","volume":"59","author":"G Kararigas","year":"2012","unstructured":"Kararigas G, Bito V, Tinel H, Becher E, Baczko I, Knosalla C, Albrecht-K\u00fcpper B, Sipido KR, Regitz-Zagrosek V (2012) Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. J Am Coll Cardiol 59:410\u2013417. https:\/\/doi.org\/10.1016\/j.jacc.2011.09.054","journal-title":"J Am Coll Cardiol"},{"key":"5126_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/cvr\/cvy185","volume":"115","author":"E Dworatzek","year":"2018","unstructured":"Dworatzek E, Mahmoodzadeh S, Schriever C, Kusumoto K, Kramer L, Santos G, Fliegner D, Leung Y-K, Ho S-M, Zimmermann W-H, Lutz S, Regitz-Zagrosek V (2018) Sex-specific regulation of collagen I and III expression by 17\u03b2-Estradiol in cardiac fibroblasts: role of estrogen receptors. Cardiovasc Res 115:315\u2013327. https:\/\/doi.org\/10.1093\/cvr\/cvy185","journal-title":"Cardiovasc Res"},{"key":"5126_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159\u2013173. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.243162","journal-title":"Circ Res"},{"key":"5126_CR51","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1253\/circj.cj-13-0013","volume":"77","author":"T Anzai","year":"2013","unstructured":"Anzai T (2013) Post-infarction inflammation and left ventricular remodeling: a double-edged sword. Circ J 77:580\u2013587. https:\/\/doi.org\/10.1253\/circj.cj-13-0013","journal-title":"Circ J"},{"key":"5126_CR52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG (2014) The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255\u2013265. https:\/\/doi.org\/10.1038\/nrcardio.2014.28","journal-title":"Nat Rev Cardiol"},{"key":"5126_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071249","author":"S Besse","year":"2022","unstructured":"Besse S, Nadaud S, Balse E, Pavoine C (2022) Early protective role of inflammation in cardiac remodeling and heart failure: focus on tnfalpha and resident macrophages. Cells. https:\/\/doi.org\/10.3390\/cells11071249","journal-title":"Cells"},{"key":"5126_CR54","doi-asserted-by":"publisher","first-page":"664457","DOI":"10.3389\/fimmu.2021.664457","volume":"12","author":"I Kologrivova","year":"2021","unstructured":"Kologrivova I, Shtatolkina M, Suslova T, Ryabov V (2021) Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction. Front Immunol 12:664457. https:\/\/doi.org\/10.3389\/fimmu.2021.664457","journal-title":"Front Immunol"},{"key":"5126_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","volume":"14","author":"N Suthahar","year":"2017","unstructured":"Suthahar N, Meijers WC, Sillje HHW, de Boer RA (2017) From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities. Curr Heart Fail Rep 14:235\u2013250. https:\/\/doi.org\/10.1007\/s11897-017-0343-y","journal-title":"Curr Heart Fail Rep"},{"key":"5126_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00395-019-0722-5","volume":"114","author":"L Bacmeister","year":"2019","unstructured":"Bacmeister L, Schwarzl M, Warnke S, Stoffers B, Blankenberg S, Westermann D, Lindner D (2019) Inflammation and fibrosis in murine models of heart failure. Basic Res Cardiol 114:19. https:\/\/doi.org\/10.1007\/s00395-019-0722-5","journal-title":"Basic Res Cardiol"},{"key":"5126_CR57","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/ATVBAHA.120.315865","volume":"41","author":"C Mazzotta","year":"2021","unstructured":"Mazzotta C, Basu S, Gower AC, Karki S, Farb MG, Sroczynski E, Zizza E, Sarhan A, Pande AN, Walsh K, Dobrilovic N, Gokce N (2021) Perivascular adipose tissue inflammation in ischemic heart disease. Arterioscler Thromb Vasc Biol 41:1239\u20131250. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315865","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5126_CR58","doi-asserted-by":"publisher","first-page":"146093","DOI":"10.1016\/j.gene.2021.146093","volume":"813","author":"H Wang","year":"2022","unstructured":"Wang H, Ji Y, Ding Z, Guo W, Zou Y (2022) Gene expression profiling and functional analysis of ventricular tissues from murine transverse aortic constriction. Gene 813:146093. https:\/\/doi.org\/10.1016\/j.gene.2021.146093","journal-title":"Gene"},{"key":"5126_CR59","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1093\/cvr\/cvad093","volume":"119","author":"CD Smart","year":"2023","unstructured":"Smart CD, Fehrenbach DJ, Wassenaar JW, Agrawal V, Fortune NL, Dixon DD, Cottam MA, Hasty AH, Hemnes AR, Doran AC, Gupta DK, Madhur MS (2023) Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure. Cardiovasc Res 119:2312\u20132328. https:\/\/doi.org\/10.1093\/cvr\/cvad093","journal-title":"Cardiovasc Res"},{"key":"5126_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00395-021-00897-1","volume":"116","author":"M Rao","year":"2021","unstructured":"Rao M, Wang X, Guo G, Wang L, Chen S, Yin P, Chen K, Chen L, Zhang Z, Chen X, Hu X, Hu S, Song J (2021) Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level. Basic Res Cardiol 116:55. https:\/\/doi.org\/10.1007\/s00395-021-00897-1","journal-title":"Basic Res Cardiol"},{"key":"5126_CR61","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cardiores.2004.03.025","volume":"63","author":"S Pikkarainen","year":"2004","unstructured":"Pikkarainen S, Tokola H, Kerkel\u00e4 R, Ruskoaho H (2004) GATA transcription factors in the developing and adult heart. Cardiovasc Res 63:196\u2013207. https:\/\/doi.org\/10.1016\/j.cardiores.2004.03.025","journal-title":"Cardiovasc Res"},{"key":"5126_CR62","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/01.RES.0000215985.18538.c4","volume":"98","author":"T Oka","year":"2006","unstructured":"Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, Molkentin JD (2006) Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 98:837\u2013845. https:\/\/doi.org\/10.1161\/01.RES.0000215985.18538.c4","journal-title":"Circ Res"},{"key":"5126_CR63","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.gde.2024.102207","volume":"87","author":"C Achour","year":"2024","unstructured":"Achour C, Oberdoerffer S (2024) NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease. Curr Opin Genet Dev 87:102207. https:\/\/doi.org\/10.1016\/j.gde.2024.102207","journal-title":"Curr Opin Genet Dev"},{"key":"5126_CR64","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41586-018-0021-6","volume":"556","author":"R Ayala","year":"2018","unstructured":"Ayala R, Willhoft O, Aramayo RJ, Wilkinson M, McCormack EA, Ocloo L, Wigley DB, Zhang X (2018) Structure and regulation of the human INO80-nucleosome complex. Nature 556:391\u2013395. https:\/\/doi.org\/10.1038\/s41586-018-0021-6","journal-title":"Nature"},{"key":"5126_CR65","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2013.08.016","volume":"154","author":"A Tosi","year":"2013","unstructured":"Tosi A, Haas C, Herzog F, Gilmozzi A, Berninghausen O, Ungewickell C, Gerhold CB, Lakomek K, Aebersold R, Beckmann R, Hopfner KP (2013) Structure and subunit topology of the INO80 chromatin remodeler and its nucleosome complex. Cell 154:1207\u20131219. https:\/\/doi.org\/10.1016\/j.cell.2013.08.016","journal-title":"Cell"},{"key":"5126_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2024.2386126","author":"W Wei","year":"2024","unstructured":"Wei W, Si Y, Li Z, Yin X, Ma G, Shi J, Li C, Yu L, Zheng W, Wang Y, Liu K, Xu R, Cui S (2024) Exploring the potential mechanism of Chinese herbal medicine Fuzi on aplastic anemia based on UHPLC-MS\/MS method combined with network pharmacology and molecular docking. Nat Prod Res. https:\/\/doi.org\/10.1080\/14786419.2024.2386126","journal-title":"Nat Prod Res"},{"key":"5126_CR67","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1875-5364(24)60558-3","volume":"22","author":"J Li","year":"2024","unstructured":"Li J, Guo H, Dong Y, Yuan S, Wei X, Zhang Y, Dong L, Wang F, Bai T, Yang Y (2024) Polysaccharides from Chinese herbal medicine: a review on the hepatoprotective and molecular mechanism. Chin J Nat Med 22:4\u201314. https:\/\/doi.org\/10.1016\/S1875-5364(24)60558-3","journal-title":"Chin J Nat Med"},{"key":"5126_CR68","doi-asserted-by":"publisher","first-page":"116694","DOI":"10.1016\/j.biopha.2024.116694","volume":"175","author":"YX Yao","year":"2024","unstructured":"Yao YX, Yu YJ, Dai S, Zhang CY, Xue XY, Zhou ML, Yao CH, Li YX (2024) Kaempferol efficacy in metabolic diseases: molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis. Biomed Pharmacother 175:116694. https:\/\/doi.org\/10.1016\/j.biopha.2024.116694","journal-title":"Biomed Pharmacother"},{"key":"5126_CR69","doi-asserted-by":"publisher","first-page":"115880","DOI":"10.1016\/j.biopha.2023.115880","volume":"169","author":"T Yu","year":"2023","unstructured":"Yu T, Xu J, Wang Q, Han X, Tu Y, Wang Y, Luo W, Wang M, Liang G (2023) 20(S)-ginsenoside Rh2 inhibits angiotensin-2 mediated cardiac remodeling and inflammation associated with suppression of the JNK\/AP-1 pathway. Biomed Pharmacother 169:115880. https:\/\/doi.org\/10.1016\/j.biopha.2023.115880","journal-title":"Biomed Pharmacother"},{"key":"5126_CR70","doi-asserted-by":"publisher","first-page":"113075","DOI":"10.1016\/j.biopha.2022.113075","volume":"150","author":"M Wang","year":"2022","unstructured":"Wang M, Luo W, Yu T, Liang S, Sun J, Zhang Y, Han X, Long X, Liang G, Li G (2022) Corynoline protects ang II-induced hypertensive heart failure by increasing PPARalpha and Inhibiting NF-kappaB pathway. Biomed Pharmacother 150:113075. https:\/\/doi.org\/10.1016\/j.biopha.2022.113075","journal-title":"Biomed Pharmacother"},{"key":"5126_CR71","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1111\/jcmm.14181","volume":"23","author":"S Li","year":"2019","unstructured":"Li S, Peng B, Luo X, Sun H, Peng C (2019) Anacardic acid attenuates pressure-overload cardiac hypertrophy through inhibiting histone acetylases. J Cell Mol Med 23:2744\u20132752. https:\/\/doi.org\/10.1111\/jcmm.14181","journal-title":"J Cell Mol Med"},{"key":"5126_CR72","doi-asserted-by":"publisher","first-page":"1130635","DOI":"10.3389\/fcvm.2023.1130635","volume":"10","author":"Z Wang","year":"2023","unstructured":"Wang Z, Shi W, Wu T, Peng T, Wang X, Liu S, Yang Z, Wang J, Li PL, Tian R, Hong Y, Yang H, Bai L, Hu Y, Cheng X, Li H, Zhang XJ, She ZG (2023) A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure. Front Cardiovasc Med 10:1130635. https:\/\/doi.org\/10.3389\/fcvm.2023.1130635","journal-title":"Front Cardiovasc Med"},{"key":"5126_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bcp.2014.04.011","volume":"90","author":"FG Spinale","year":"2014","unstructured":"Spinale FG, Villarreal F (2014) Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors. Biochem Pharmacol 90:7\u201315. https:\/\/doi.org\/10.1016\/j.bcp.2014.04.011","journal-title":"Biochem Pharmacol"},{"key":"5126_CR74","doi-asserted-by":"publisher","first-page":"1130388","DOI":"10.3389\/fcvm.2023.1130388","volume":"10","author":"ZM Xia","year":"2023","unstructured":"Xia ZM, Song MY, Chen YL, Cui G, Fan D (2023) TIMP3 induces gene expression partly through PI3K and their association with vascularization and heart rate. Front Cardiovasc Med 10:1130388. https:\/\/doi.org\/10.3389\/fcvm.2023.1130388","journal-title":"Front Cardiovasc Med"},{"key":"5126_CR75","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphys.2020.00661","volume":"11","author":"D Fan","year":"2020","unstructured":"Fan D, Kassiri Z (2020) Biology of tissue inhibitor of metalloproteinase 3 (TIMP3), and its therapeutic implications in cardiovascular pathology. Front Physiol 11:661. https:\/\/doi.org\/10.3389\/fphys.2020.00661","journal-title":"Front Physiol"},{"key":"5126_CR76","doi-asserted-by":"publisher","first-page":"H1012","DOI":"10.1152\/ajpheart.00246.2010","volume":"299","author":"V Kandalam","year":"2010","unstructured":"Kandalam V, Basu R, Abraham T, Wang X, Awad A, Wang W, Lopaschuk GD, Maeda N, Oudit GY, Kassiri Z (2010) Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction. Am J Physiol Heart Circ Physiol 299:H1012\u2013H1023. https:\/\/doi.org\/10.1152\/ajpheart.00246.2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5126_CR77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1124\/jpet.120.000047","volume":"375","author":"DC Lobb","year":"2020","unstructured":"Lobb DC, Doviak H, Brower GL, Romito E, O\u2019Neill JW, Smith S, Shuman JA, Freels PD, Zellars KN, Freeburg LA, Khakoo AY, Lee T, Spinale FG (2020) Targeted injection of a truncated form of tissue inhibitor of metalloproteinase 3 alters post-myocardial infarction remodeling. J Pharmacol Exp Ther 375:296\u2013307. https:\/\/doi.org\/10.1124\/jpet.120.000047","journal-title":"J Pharmacol Exp Ther"},{"key":"5126_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.matbio.2024.02.008","volume":"128","author":"E Angeli","year":"2024","unstructured":"Angeli E, Jordan M, Otto M, Stojanovic SD, Karsdal M, Bauersachs J, Thum T, Fiedler J, Genovese F (2024) The role of fibrosis in cardiomyopathies: an opportunity to develop novel biomarkers of disease activity. Matrix Biol 128:65\u201378. https:\/\/doi.org\/10.1016\/j.matbio.2024.02.008","journal-title":"Matrix Biol"},{"key":"5126_CR79","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.molmet.2015.07.007","volume":"4","author":"R Stohr","year":"2015","unstructured":"Stohr R, Kappel BA, Carnevale D, Cavalera M, Mavilio M, Arisi I, Fardella V, Cifelli G, Casagrande V, Rizza S, Cattaneo A, Mauriello A, Menghini R, Lembo G, Federici M (2015) TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice. Mol Metab 4:741\u2013752. https:\/\/doi.org\/10.1016\/j.molmet.2015.07.007","journal-title":"Mol Metab"},{"key":"5126_CR80","doi-asserted-by":"publisher","first-page":"e126525","DOI":"10.1172\/jci.insight.126525","volume":"5","author":"YM Kim","year":"2020","unstructured":"Kim YM, Lakin R, Zhang H, Liu J, Sachedina A, Singh M, Wilson E, Perez M, Verma S, Quertermous T, Olgin J, Backx PH, Ashley EA (2020) Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation. JCI Insight 5:e126525. https:\/\/doi.org\/10.1172\/jci.insight.126525","journal-title":"JCI Insight"},{"key":"5126_CR81","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/hypertensionaha.117.10156","volume":"70","author":"ZZ Zhang","year":"2017","unstructured":"Zhang ZZ, Wang W, Jin HY, Chen X, Cheng YW, Xu YL, Song B, Penninger JM, Oudit GY, Zhong JC (2017) Apelin is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction. Hypertension 70:1165\u20131175. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10156","journal-title":"Hypertension"},{"key":"5126_CR82","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/ijms20020239","volume":"20","author":"T Sato","year":"2019","unstructured":"Sato T, Kadowaki A, Suzuki T, Ito H, Watanabe H, Imai Y, Kuba K (2019) Loss of apelin augments angiotensin ii-induced cardiac dysfunction and pathological remodeling. Int J Mol Sci 20:239. https:\/\/doi.org\/10.3390\/ijms20020239","journal-title":"Int J Mol Sci"},{"key":"5126_CR83","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11010-014-2008-4","volume":"391","author":"OI Pisarenko","year":"2014","unstructured":"Pisarenko OI, Lankin VZ, Konovalova GG, Serebryakova LI, Shulzhenko VS, Timoshin AA, Tskitishvili OV, Pelogeykina YA, Studneva IM (2014) Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion. Mol Cell Biochem 391:241\u2013250. https:\/\/doi.org\/10.1007\/s11010-014-2008-4","journal-title":"Mol Cell Biochem"},{"key":"5126_CR84","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/cvr\/cvad171","volume":"119","author":"FA Chapman","year":"2023","unstructured":"Chapman FA, Maguire JJ, Newby DE, Davenport AP, Dhaun N (2023) Targeting the apelin system for the treatment of cardiovascular diseases. Cardiovasc Res 119:2683\u20132696. https:\/\/doi.org\/10.1093\/cvr\/cvad171","journal-title":"Cardiovasc Res"},{"key":"5126_CR85","doi-asserted-by":"publisher","first-page":"170697","DOI":"10.1016\/j.peptides.2021.170697","volume":"147","author":"AA de Oliveira","year":"2022","unstructured":"de Oliveira AA, Vergara A, Wang X, Vederas JC, Oudit GY (2022) Apelin pathway in cardiovascular, kidney, and metabolic diseases: therapeutic role of apelin analogs and apelin receptor agonists. Peptides 147:170697. https:\/\/doi.org\/10.1016\/j.peptides.2021.170697","journal-title":"Peptides"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05126-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:18:25Z","timestamp":1740039505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05126-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,5]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["5126"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05126-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,5]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}